Fifth Third Wealth Advisors LLC Gilead Sciences, Inc. Transaction History
Fifth Third Wealth Advisors LLC
- $2.71 Trillion
- Q3 2025
A detailed history of Fifth Third Wealth Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 13,535 shares of GILD stock, worth $1.68 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,535
Previous 12,763
6.05%
Holding current value
$1.68 Million
Previous $1.42 Billion
6.17%
% of portfolio
0.06%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...